Progress of targeted therapy of intrahepatic cholangiocarcinoma

Q4 Medicine
Yeming Zhou, Wei Jiang, Jing Huang, Y. Hua, Caide Lu
{"title":"Progress of targeted therapy of intrahepatic cholangiocarcinoma","authors":"Yeming Zhou, Wei Jiang, Jing Huang, Y. Hua, Caide Lu","doi":"10.3760/CMA.J.ISSN.1007-8118.2019.12.019","DOIUrl":null,"url":null,"abstract":"The incidence of intrahepatic cholangiocarcinoma (ICC) has been increasing year by year. For most patients, surgical resection is not suitable when they are diagnosed as ICC. Conventional chemotherapy and radiotherapy are not effective for the long-term survival rate of ICC patients and lead to the poor overall prognosis. In recent years, with the deepening understanding about the molecular mechanism of biliary malignant tumors, some key genes and signaling pathways related to the pathogenesis of ICC have been identified, providing new ideas for the targeted therapy. In this paper, major molecular mechanisms and targeted therapies of ICC are reviewed. \n \n \nKey words: \nBile duct neoplasm; Cholangiocarcinoma; Intrahepatic cholangiocarcinoma; Molecular targeted therapy; Progress","PeriodicalId":10021,"journal":{"name":"中华肝胆外科杂志","volume":"25 1","pages":"956-960"},"PeriodicalIF":0.0000,"publicationDate":"2019-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华肝胆外科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1007-8118.2019.12.019","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The incidence of intrahepatic cholangiocarcinoma (ICC) has been increasing year by year. For most patients, surgical resection is not suitable when they are diagnosed as ICC. Conventional chemotherapy and radiotherapy are not effective for the long-term survival rate of ICC patients and lead to the poor overall prognosis. In recent years, with the deepening understanding about the molecular mechanism of biliary malignant tumors, some key genes and signaling pathways related to the pathogenesis of ICC have been identified, providing new ideas for the targeted therapy. In this paper, major molecular mechanisms and targeted therapies of ICC are reviewed. Key words: Bile duct neoplasm; Cholangiocarcinoma; Intrahepatic cholangiocarcinoma; Molecular targeted therapy; Progress
肝内胆管癌靶向治疗进展
肝内胆管癌的发病率逐年上升。对于大多数患者来说,当他们被诊断为ICC时,手术切除是不合适的。常规化疗和放疗对ICC患者的长期生存率无效,并导致不良的整体预后。近年来,随着对胆道恶性肿瘤分子机制认识的加深,一些与ICC发病机制相关的关键基因和信号通路被发现,为靶向治疗提供了新的思路。本文综述了ICC的主要分子机制和靶向治疗。关键词:胆管肿瘤;胆管癌;肝内胆管癌;分子靶向治疗;进度
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
中华肝胆外科杂志
中华肝胆外科杂志 Medicine-Gastroenterology
CiteScore
0.20
自引率
0.00%
发文量
7101
期刊介绍: Chinese Journal of Hepatobiliary Surgery is an academic journal organized by the Chinese Medical Association and supervised by the China Association for Science and Technology, founded in 1995. The journal has the following columns: review, hot spotlight, academic thinking, thesis, experimental research, short thesis, case report, synthesis, etc. The journal has been recognized by Beida Journal (Chinese Journal of Humanities and Social Sciences). Chinese Journal of Hepatobiliary Surgery has been included in famous databases such as Peking University Journal (Chinese Journal of Humanities and Social Sciences), CSCD Source Journals of China Science Citation Database (with Extended Version) and so on, and it is one of the national key academic journals under the supervision of China Association for Science and Technology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信